Nanoencapsulated lycopene as a therapeutic strategy for neurodegenerative diseases: an integrative review

This study aims to identify the lycopene nanoformulations that have already been investigated and to evaluate whether experimental treatment with nanoencapsulated lycopene demonstrates efficacy in controlling or alleviating symptoms of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Furthermore, it seeks to highlight the advantages and disadvantages of nanoformulation in comparison to other means of delivering the active ingredient.